JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SSBK
4951
DELISTED
Southern States Bancshares
SSBK
| $194K | ﹤0.01% |
7,143
-6,176
| -46% | -$158K |
2023 Q1
5 quarters
|
|
|
PVBC
4952
DELISTED
Provident Bancorp
PVBC
| $194K | ﹤0.01% |
19,019
-9,393
| -33% | -$86.6K |
2017 Q4
26 quarters
|
|
4953
Orthofix Medical
OFIX
$370M
| $193K | ﹤0.01% |
14,531
-31,866
| -69% | -$437K |
2015 Q2
36 quarters
|
|
|
APLT
4954
DELISTED
Applied Therapeutics
APLT
| $192K | ﹤0.01% |
41,138
-137,786
| -77% | -$652K |
2019 Q3
19 quarters
|
|
|
EBTC
4955
DELISTED
Enterprise Bancorp
EBTC
| $191K | ﹤0.01% |
7,678
-11,031
| -59% | -$270K |
2017 Q4
26 quarters
|
|
4956
GeneDx Holdings
WGS
$2.18B
| $190K | ﹤0.01% |
7,272
+7,238
| +21,288% | +$137K |
2021 Q4
10 quarters
|
|
4957
Innovator US Equity Power Buffer ETF April
PAPR
$964M
| $190K | ﹤0.01% |
5,483
-6,393
| -54% | -$216K |
2022 Q4
6 quarters
|
|
4958
1stdibs.com
DIBS
$135M
| $190K | ﹤0.01% |
42,300
-52,923
| -56% | -$289K |
2021 Q2
12 quarters
|
|
4959
Orange County Bancorp
OBT
$506M
| $190K | ﹤0.01% |
7,178
-11,620
| -62% | -$273K |
2023 Q1
5 quarters
|
|
4960
Phibro Animal Health
PAHC
$1.51B
| $189K | ﹤0.01% |
11,243
-5,327
| -32% | -$85.6K |
2014 Q2
40 quarters
|
|
4961
Shinhan Financial Group
SHG
$36.6B
| $186K | ﹤0.01% |
5,348
+418
| +8% | +$14.1K |
2013 Q3
43 quarters
|
|
4962
International General Insurance
IGIC
$1.05B
| $186K | ﹤0.01% |
13,295
+10,970
| +472% | +$153K |
2024 Q1
1 quarter
|
|
|
JKS
4963
JinkoSolar
JKS
$479M
| $186K | ﹤0.01% |
8,971
+8,357
| +1,361% | +$206K |
2019 Q4
18 quarters
|
|
4964
RCM Technologies
RCMT
$299M
| $185K | ﹤0.01% |
9,900
+7,494
| +311% | +$149K |
2023 Q4
2 quarters
|
|
4965
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$350M
| $185K | ﹤0.01% |
+5,376
| New | +$191K |
2024 Q2
0 quarters
|
|
|
CVE.WS
4966
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
| – | – |
0
| – | – |
2021 Q1
13 quarters
|
|
4967
Avita Medical
RCEL
$393M
| $185K | ﹤0.01% |
23,359
+13,075
| +127% | +$124K |
2023 Q1
5 quarters
|
|
|
DBEH
4968
DELISTED
iMGP DBi Hedge Strategy ETF
DBEH
| $184K | ﹤0.01% |
+6,797
| New | +$184K |
2024 Q2
0 quarters
|
|
4969
Heron Therapeutics
HRTX
$66M
| $183K | ﹤0.01% |
52,224
+9,740
| +23% | +$29.9K |
2015 Q3
35 quarters
|
|
4970
PUT
Packaging Corp of America
PKG
$20.4B
| $183K | ﹤0.01% |
1,000
| – | – |
2024 Q1
1 quarter
|
|
4971
Innodata
INOD
$2.41B
| $183K | ﹤0.01% |
12,309
+1,532
| +14% | +$15.9K |
2023 Q2
4 quarters
|
|
4972
Village Super Market
VLGEA
$681M
| $182K | ﹤0.01% |
6,873
-11,589
| -63% | -$326K |
2015 Q2
36 quarters
|
|
4973
Bowman Consulting
BWMN
$738M
| $181K | ﹤0.01% |
5,684
-737
| -11% | -$23.3K |
2022 Q4
6 quarters
|
|
4974
Red River Bancshares
RRBI
$681M
| $180K | ﹤0.01% |
3,756
-6,354
| -63% | -$297K |
2019 Q2
20 quarters
|
|
4975
FT Vest US Equity Moderate Buffer ETF January
GJAN
$444M
| $180K | ﹤0.01% |
+4,874
| New | +$176K |
2024 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.